Basic Search
|
Summaries
|
Advanced SearchViolation Tracker Individual Record
Company: Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc.
Current Parent Company:
Teva Pharmaceutical Industries
Parent at the Time of the Penalty Announcement:
subscribe to see this data field
Penalty: $450,000,000
Year: 2024
Date: October 10, 2024
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: kickbacks and bribery
Mega-Scandal:
Healthcare Kickbacks
Violation Description: Teva Pharmaceuticals USA Inc. (Teva USA) and Teva Neuroscience Inc. (collectively, Teva) agreed to pay $450 million to resolve two matters that allege Teva violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA). The settlement encompassed two alleged kickback schemes. First, Teva agreed to resolve allegations in a complaint the United States filed in the District of Massachusetts in August 2020 that Teva violated and conspired to violate the AKS and FCA by paying Medicare patients' cost sharing obligations (copays) for the multiple sclerosis drug Copaxone from 2006 through 2017, while steadily raising Copaxone's price. Second, Teva USA agreed to resolve separate allegations that it conspired with other generic drug manufacturers to fix prices for pravastatin, a drug widely used to treat high cholesterol and triglyceride levels, as well as two other generic drugs, clotrimazole and tobramycin. Teva USA previously entered into a deferred prosecution agreement with the Justice Department's Antitrust Division to resolve related criminal charges (see separate entry). Under the new civil settlement, Teva agreed to resolve allegations that the benefits it received under its price fixing scheme constituted illegal kickbacks.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
HQ Country of Current Parent: Israel
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data:
(click here)
Archived Source:
(click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the
Update Log.